Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

pre-register

PROGRAM chair

Peter van de Kerkhof, MD, PhD, Chief Medical Officer
International Psoriasis Council
Amsterdam, Netherlands

Professor Peter van de Kerkhof served as head of the department Dermatology at the Radboud University Nijmegen Medical Centre, The Netherlands, since 1992 and is currently a Professor Emeritus there. He graduated in medicine from the Catholic University of Nijmegen in 1978 and trained in Dermatology at the St. Radboud Hospital, Nijmegen. In 1983 and in 1990 he completed his theses in the faculty of medicine and faculty of sciences resp. Between 1980 and 1984 he completed his training as a dermatologist. Research interests of Professor van de Kerkhof are psoriasis, disorders of keratinization, inflammation and clinical pharmacology of the skin. He has been president of major European Dermatological societies such as European Society of Dermatological Research and European Dermatology Forum. He is member of the editorial board of several international dermatological journals. He is an author or coauthor of more than 600 peer reviewed dermatological journals. He joined the IPC Staff as Chief Medical Officer in July 2018.

Last Updated: 1/9/2019 12:00:00 AM

Program faculty 

Errol Prens, MD, PhD
Erasmus University Medical Center
Rotterdam, Netherlands

Errol Prens (1956) earned his MD degree in 1981 at the University of Groningen and became a certified Dermatologist in 1985 after receiving his training in the department of Dermatology Erasmus University in Rotterdam. He joined the department of Immunology of the Erasmus MC for research on skin inflammation, resulting in his thesis 'Immunopathophysiology of psoriasis; studies on accessory cells, cytokines and their receptors', Erasmus University Rotterdam (1992). Certification as an Immunologist followed in 1993 (SMWBO). He combined his position as a postdoctoral fellow and leader of the Experimental Immunodermatology group in the department of Immunology of the Erasmus MC, with his clinical tasks as an all-round dermatologist in Ziekenhuis Walcheren in Vlissingen. He is a reviewer for several international dermatological and immunological journals, co-founder and board member of the Dutch Society for Experimental Dermatology, councillor of the International Psoriasis Council, and member of the scientific committee of the international congress “Psoriasis from Gene to Clinic” in London.

Last Updated: 1/25/2018 12:00:00 AM

Marieke Seyger, MD, PhD
Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands

Marieke Seyger is Associate Professor of (pediatric) dermatology in the Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands. She gained her medical degree in 1995, received her Ph.D. in 1999 and qualified as a dermatologist in 2002. Dr Seyger has established the European Working group on Pediatric Psoriasis. She is Councilor of the International Psoriasis Council, Associate of the International Eczema Council, secretary of the Dutch Task Group on Pediatric Dermatology and secretary of the Dutch Society for Experimental Dermatology. She participated in the Dutch guideline for psoriasis and wrote the Dutch pediatric psoriasis guideline. Dr Seyger is an invited speaker at many international conferences. She serves a an author of the book chapter on the treatment of pediatric psoriasis in the next edition of Harper's Textbook of Pediatric Dermatology and has authored and co-authored over 100 articles in peer-reviewed journals.

Last Updated: 1/25/2018 12:00:00 AM

Fernando Valenzuela , MD
University of Chile
Santiago, Chile

Dr. Valenzuela is currently Associate Professor of Dermatology at the University of Chile in Santiago. He has received multiple awards from his medical school days to the present in addition to working closely with Dr. Kim Papp. He is highly regarded by all his colleagues in Latin America and attends all SOLAPSO and RADLA meetings in Latin America where he is frequently featured as a main speaker. He has been working and publishing about tofacitinib clinical efficacy, its association with viral infections and the improvement on quality of life.

Last Updated: 11/6/2017 12:00:00 AM

Ronald Vender, MD, FRCPC
Dermatrials Research
Hamilton, Ontario, Canada

Dr. Ron Vender is a Dermatologist who currently practices in Hamilton. He is the founder and director of Dermatrials Research Incorporated and Venderm Innovations in Psoriasis.  He has participated as principal investigator in over 100 clinical trials. He is Associate Clinical Professor at McMaster University in the Department of Medicine, Division of Dermatology. He is Honorary Staff at St. Joseph’s Healthcare in Hamilton ON. Dr. Vender serves on the editorial board of the Journal of Cutaneous Medicine and Surgery reviewer for the JEADV, JAAD, and BJD. He is one of eight Canadians elected to the International Psoriasis Council, a member of the Canadian Professors of Dermatology and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. He represents Canada on several Global educational steering committees as well as international advisory boards. He has published many peer-reviewed manuscripts and has had posters, abstracts and lectures presented internationally.

Last Updated: 2/14/2019 12:00:00 AM

This website uses cookies. Please ensure your cookies are enabled. 
OK